EVE Health Group Raises $1.1M to Accelerate Launch of Dyspro and Libbo

• Placement of 36.7 million shares at 3 cents each to raise $1.1 million
• Free attaching options offered on a 1-for-2 basis to placement subscribers
• Options and shares issued to lead manager and corporate adviser subject to shareholder approval
• Funds earmarked for commercial rollout, regulatory progress, and general working capital